Hospital Readmissions and Mortality Among Fee‐for‐Service Medicare Patients With Minor Stroke or Transient Ischemic Attack: Findings From the COMPASS Cluster‐Randomized Pragmatic Trial

Author:

Bushnell Cheryl D.1ORCID,Kucharska‐Newton Anna M.23,Jones Sara B.3,Psioda Matthew A.4ORCID,Johnson Anna M.3ORCID,Daras Laurie C.5,Halladay Jacqueline R.6ORCID,Prvu Bettger Janet7ORCID,Freburger Janet K.8ORCID,Gesell Sabina B.9ORCID,Coleman Sylvia W.1,Sissine Mysha E.1ORCID,Wen Fang3,Hunt Gary P.10ORCID,Rosamond Wayne D.3,Duncan Pamela W.1ORCID

Affiliation:

1. Department of Neurology Wake Forest Baptist Health Winston‐Salem NC

2. Department of Epidemiology College of Public Health University of Kentucky Lexington KY

3. Department of Epidemiology Gillings School of Global Public Health University of North Carolina at Chapel Hill NC

4. Department of Biostatistics Gillings School of Global Public Health University of North Carolina at Chapel Hill NC

5. Insight Policy Research Arlington VA

6. Department of Family Medicine University of North Carolina School of Medicine Chapel Hill NC

7. Duke University School of Medicine Durham NC

8. Department of Physical Therapy School of Health and Rehabilitation Sciences University of Pittsburgh PA

9. Division of Public Health Sciences Department of Social Sciences and Health Policy Wake Forest School of Medicine Winston‐Salem NC

10. Cecil G Sheps Center for Health Services Research University of North Carolina at Chapel Hill NC

Abstract

Background Mortality and hospital readmission rates may reflect the quality of acute and postacute stroke care. Our aim was to investigate if, compared with usual care (UC), the COMPASS‐TC (Comprehensive Post‐Acute Stroke Services Transitional Care) intervention (INV) resulted in lower all‐cause and stroke‐specific readmissions and mortality among patients with minor stroke and transient ischemic attack discharged from 40 diverse North Carolina hospitals from 2016 to 2018. Methods and Results Using Medicare fee‐for‐service claims linked with COMPASS cluster‐randomized trial data, we performed intention‐to‐treat analyses for 30‐day, 90‐day, and 1‐year unplanned all‐cause and stroke‐specific readmissions and all‐cause mortality between INV and UC groups, with 90‐day unplanned all‐cause readmissions as the primary outcome. Effect estimates were determined via mixed logistic or Cox proportional hazards regression models adjusted for age, sex, race, stroke severity, stroke diagnosis, and documented history of stroke. The final analysis cohort included 1069 INV and 1193 UC patients (median age 74 years, 80% White, 52% women, 40% with transient ischemic attack) with median length of hospital stay of 2 days. The risk of unplanned all‐cause readmission was similar between INV versus UC at 30 (9.9% versus 8.7%) and 90 days (19.9% versus 18.9%), respectively. No significant differences between randomization groups were seen in 1‐year all‐cause readmissions, stroke‐specific readmissions, or mortality. Conclusions In this pragmatic trial of patients with complex minor stroke/transient ischemic attack, there was no difference in the risk of readmission or mortality with COMPASS‐TC relative to UC. Our study could not conclusively determine the reason for the lack of effectiveness of the INV. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02588664.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3